| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $11.4M | +125.0% |
| SG&A Expense | $13.9M | -1.5% |
| Operating Income | -$25.7M | -34.1% |
| Interest Expense | $12K | +269.7% |
| Income Tax | $0 | — |
| Net Income | -$25.6M | -33.3% |
| EPS (Basic) | -$2.26 | +48.9% |
| EPS (Diluted) | -$2.26 | +48.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.4M | +149.8% |
| Accounts Receivable | $16K | — |
| Current Assets | $27.1M | +152.1% |
| Total Assets | $30.7M | +139.5% |
| Current Liabilities | $3.4M | +132.3% |
| Total Liabilities | $3.4M | +132.3% |
| Stockholders' Equity | $27.3M | +140.4% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.3M | -231.7% |
| Capital Expenditures | $1.9M | +30.0% |
| Investing Cash Flow | -$1.8M | -24.2% |
| Financing Cash Flow | $37.3M | +136.2% |
| Free Cash Flow | -$22.2M | -192.9% |